Cargando…

Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival

AIM: To determine whether cyclooxygenase-2 (COX-2) and prostaglandin E1 receptor (EP(1)) contribute to disease and whether they help predict prognosis. METHODS: We retrospectively reviewed the records of 116 patients with hepatocellular carcinoma (HCC) who underwent surgery between 2008 and 2011 at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hao-Jie, Jiang, Jing-Hang, Yang, Yu-Ting, Yang, Xiang-Di, Guo, Zhe, Qi, Ya-Peng, Zeng, Feng-Hua, Zhang, Ke-Lan, Chen, Neng-Zhi, Xiang, Bang-De, Li, Le-Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075554/ https://www.ncbi.nlm.nih.gov/pubmed/27818595 http://dx.doi.org/10.3748/wjg.v22.i39.8798

Ejemplares similares

Cyclooxygenase and Prostaglandin in Cancer
por: Kim, Jong-Woo
Publicado: (2012)

Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer
por: Ma, Wen-Juan, et al.
Publicado: (2018)

Expression and cellular localization of cyclooxygenases and prostaglandin E synthases in the hemorrhagic brain
por: Wu, Tao, et al.
Publicado: (2011)

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression
por: Li, You-Cai, et al.
Publicado: (2018)

Upregulation of Prostaglandin Receptor EP(1) Expression Involves Its Association with Cyclooxygenase-2
por: Sood, Rapita, et al.
Publicado: (2014)

Hypoxia Induces Macrophage tnfa Expression via Cyclooxygenase and Prostaglandin E2 in vivo
por: Lewis, Amy, et al.
Publicado: (2019)

Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors
por: Kim, Gheun-Ho
Publicado: (2008)

Cyclooxygenase 2 and Prostaglandin E2 are not Involved in N-Nitrosodiethylamine-Initiated Early Rat Hepatocarcinogenesis
por: Said, Mahmoud M., et al.
Publicado: (2009)

Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma
por: Niu, Xiang-Ke, et al.
Publicado: (2021)

Prostaglandin D2 enhances interleukin -1beta- induced cyclooxygenase-2 expression in osteoarthritic cartilage
por: Zayed, N, et al.
Publicado: (2010)

Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer
por: Howe, Louise R
Publicado: (2007)

Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
por: Nørregaard, Rikke, et al.
Publicado: (2015)

Cyclooxygenase 2 expression in pterygium
por: Chiang, Chun-Chi, et al.
Publicado: (2007)

Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study
por: Zhang, Ge, et al.
Publicado: (2022)

Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysis
por: Chen, Guodong, et al.
Publicado: (2016)

Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
por: Ye, Jia-Zhou, et al.
Publicado: (2017)

Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence
por: Zhang, Wei, et al.
Publicado: (2017)

High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation
por: He, Jia-Jia, et al.
Publicado: (2021)

Dual energy computed tomography for detection of metastatic lymph nodes in patients with hepatocellular carcinoma
por: Zeng, Yu-Rong, et al.
Publicado: (2019)

Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis
por: Chen, Li-Xing, et al.
Publicado: (2020)

Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis
por: Korotkova, M, et al.
Publicado: (2008)

Impacts of Cytosolic Phospholipase A2, 15-Prostaglandin Dehydrogenase, and Cyclooxygenase-2 Expressions on Tumor Progression in Colorectal Cancer
por: Lim, Sung Chul, et al.
Publicado: (2010)

Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming
por: Muraoka, Naoto, et al.
Publicado: (2019)

Expression Pattern of Cyclooxygenase-2 in Normal Rat Epidermis and Pilosebaceous Unit during Hair Cycle
por: Xu, Yuanxu, et al.
Publicado: (2008)

Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma
por: Wang, Jian-Ping, et al.
Publicado: (2020)

Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma
por: Wang, Lin, et al.
Publicado: (2020)

Ethanol extract of Angelica gigas inhibits croton oil-induced inflammation by suppressing the cyclooxygenase - prostaglandin pathway
por: Shin, Sunhee, et al.
Publicado: (2010)

Clinical implications of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 in breast invasive ductal carcinoma
por: Bai, Jie, et al.
Publicado: (2023)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Dysregulation of phospholipase and cyclooxygenase expression is involved in Schizophrenia
por: Yang, Xuhan, et al.
Publicado: (2021)

Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number
por: Hu, Xin-Sheng, et al.
Publicado: (2022)

Expression of caspase-3 and hypoxia inducible factor 1α in hepatocellular carcinoma complicated by hemorrhage and necrosis
por: Liang, Hui, et al.
Publicado: (2021)

Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients
por: Feng, Jian, et al.
Publicado: (2022)

Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids
por: Cui, Jie, et al.
Publicado: (2014)

Prostaglandin cyclooxygenase products but not thromboxane A(2) are involved in the pathogenesis of ewthromelalgia in thrombocythaemia
por: Michiels, J. J., et al.
Publicado: (1993)

Compensatory Prostaglandin E(2) Biosynthesis in Cyclooxygenase 1 or 2 Null Cells
por: Kirtikara, Kanyawim, et al.
Publicado: (1998)

Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders
por: Yui, Kunio, et al.
Publicado: (2015)

Cyclooxygenase-2 induces angiogenesis in pancreatic cancer mediated by prostaglandin E(2)
por: Xie, Chuangao, et al.
Publicado: (2018)

Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma
por: Kono, Hiroshi, et al.
Publicado: (2016)

Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma
por: Khlaiphuengsin, Apichaya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pt3kkji608g9a8883rdnoil718